# US 2001/0012895 A1 · Heterocyclic 2-substituted ketoamides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0012895 A1
- Document ID: US20010012895A1
- Status: Published application
- Kind: A1
- Application number: 09/736,540
- Filed: 2000-12-13
- Published: 2001-08-09
- Earliest claimed: 1998-09-30
- Inventors: John McMillan McIver; Charles Raymond Degenhardt; David Joseph Eickhoff
- Web page: https://patentgrep.com/patent/US20010012895A1

## CPC

- A61K 8/41: Amines
- A61K 8/4913: {having five membered rings, e.g. pyrrolidone carboxylic acid}
- A61K 8/4926: {having six membered rings}
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 11/06: Antiasthmatics
- A61P 17/14: for baldness or alopecia
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 27/02: Ophthalmic agents
- A61P 31/04: Antibacterial agents
- A61P 31/10: Antimycotics
- A61P 37/08: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61Q 7/00: Preparations for affecting hair growth
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present disclosure describes novel compounds and compositions which are particularly useful for treating hair loss in mammals, including arresting and/or reversing hair loss and promoting hair growth. The present compounds and compositions may also be useful against a variety of disorders including, for example, multi-drug resistance, human immunodeficiency virus (HIV), cardiac injury, and neurological disorders, and may be useful for controlling parasites and invoking immunosuppression.

## Claims

### Claim 1

A compound having a structure: 69
and pharmaceutically acceptable salts, hydrates, and biohydrolyzable amides, esters, and imides thereof, wherein:
(a) V is a heteroatom wherein the heteroatom is nitrogen;
(b) R1 is selected from the group consisting of alkyl having at least 3 carbon atoms, alkenyl, heteroalkyl, heteroalkenyl, cycloalkyl, heterocycloalkyl, aryl, arylalkyl, heteroarylalkyl, arylalkenyl, and heteroarylalkenyl;
(c) Z is a saturated or unsaturated 4-, 5-, 6-, 7-, 8-, or 9-membered heterocycle optionally containing one or more additional heteroatoms selected from the group consisting of O, N, S, S(O), S(O)2, and P((O)OK);
(d) K is selected from the group consisting of hydrogen, alkyl, alkenyl, heteroalkyl, heteroalkenyl, cycloalkyl, heterocycloalkyl, aryl, arylalkyl, heteroarylalkyl, arylalkenyl, and heteroarylalkenyl;
(e) W is selected from the group consisting of nil, hydrogen, and lower alkyl;
(f) A is selected from the group consisting of nil and alkyl;
(g) X and Y are each, independently, selected from the group consisting of C(O), P(O), N, O, and S, wherein:
(i) when X is C(O) then R3 is nil and Y is selected from the group consisting of N, O, and S;
(ii) when X is P(O) then R3 is nil and Y is selected from the group consisting of N and O;
(iii) when X is N then R3 is selected from hydrogen, alkyl, and arylalkyl, Y is selected from the group consisting of C(O) and P(O), and R2 is nil;
(iv) when X is O then R3 is nil, Y is selected from the group consisting of C(O) and P(O), and R2 is nil; and
(v) when X is S then R3 is nil, Y is C(O), and R2 is nil;
(h) R2 and R3 are each independently, selected from the group consisting of nil, hydrogen, alkyl, and arylalkyl;
(i) R4 is alkyl;
(j) R5 and R6 are each, independently, selected from the group consisting of nil, hydrogen, alkyl having at least three carbon atoms, alkenyl, heteroalkyl, heteroalkenyl, cycloalkyl, heterocycloalkyl, aryl, arylalkyl, heteroarylalkyl, arylalkenyl, and heteroarylalkenyl, or wherein R5 and R6 are bonded together to form a carbocyclic or hetercyclic ring; wherein at least one of R5 or R6 is not nil or hydrogen; and wherein when A is nil and R7 and R8 are bonded together to form a 5- or 6-membered aromatic carbocyclic ring which is fused to Z, then R4, R5, and R6 are not bonded together to form a substituted or unsubstituted tetrahydronapthalene moiety;
(k) R7, R8, and R9, and R10 are each, independently, selected from the group consisting of nil hydrogen, alkyl, alkenyl, heteroalkyl, heteroalkenyl, cycloalkyl, heterocycloalkyl, aryl, arylalkyl, heteroarylalkyl, arylalkenyl, heteroarylalkenyl, halo, cyano, hydroxy, oxo, imino, —R14SR15, —R14S(O2)R15, — R14S(O)R15, —R14C(O)R15, —R14C(O)NR15R16, —R14C(O)OR15, —R14OR15, — R14NR15R16, —R14P(O)NR15,R16, —R14P(O)OR15R16, and a spiro moiety, and wherein R7 and R8 may be optionally bonded together to form an aromatic or saturated, carbocyclic or heterocyclic ring wherein the ring is fused to Z; wherein when A is nil and X is C(O) at least one of R7, R8, R9, and R10 is not nil or hydrogen;
(l) R14, and R15 are each, independently, selected from the group consisting of nil, hydrogen, alkyl, alkenyl, heteroalkyl, heteroalkenyl, cycloalkyl, heterocycloalkyl, aryl, arylalkyl, heteroarylalkyl, arylalkenyl, and heteroarylalkenyl; and
(m) R16 is selected from the group consisting of hydrogen and alkyl.

### Claim 2 (depends on 1)

A compound according to claim 1 wherein Z is a 5-, 6-, or 7-membered heterocycle optionally containing one or more of the additional heteroatoms which are selected from the group consisting of O, N, S, S(O), and S(O)2, and wherein W is hydrogen.

### Claim 3 (depends on 2)

A compound according to claim 2 wherein Z is a 5-membered heterocycle.

### Claim 4 (depends on 3)

A compound according to claim 3 wherein A is nil, X is C(O), Y is N, and R2 is hydrogen.

### Claim 5 (depends on 4)

A compound according to claim 4 wherein R8, R9 and R10 are each, independently, selected from the group consisting of nil and hydrogen.

### Claim 6 (depends on 5)

A compound according to claim 5 which is selected from the group consisting of: 70

### Claim 7 (depends on 4)

A compound according to claim 4 wherein R7 and R8 are bonded together to form a 5-, 6-, or 7-membered carbocyclic or heterocyclic aromatic ring which is fused to Z.

### Claim 8 (depends on 7)

A compound according to claim 7 which is selected from the group consisting of: 71
wherein R18, R19, and R20 are each, independently, selected from the group consisting of hydrogen, alkyl, alkenyl, heteroalkyl, heteroalkenyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, arylalkenyl, heteroarylalkenyl, halogen, hydroxy, oxo, alkoxy, aryloxy, —SR21, —S(O2)R21, —S(O)R22, —C(O)R21, —C(O)OR21, —C(O)NR21R23, — C(S)R21, —OR21, and —NR21,R22, and wherein R2,, R22, and R23 are each, independently, selected from the group consisting of hydrogen, alkyl, alkenyl, heteroalkyl, heteroalkenyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, arylalkenyl, and heteroarylalkenyl.

### Claim 9 (depends on 8)

A compound according to claim 8 which is selected from the group consisting of: 72
wherein R30 is selected from the group consisting of —OR32 and —OCH2C(O)OR32, wherein R32 is selected from the group consisting of hydrogen and alkyl.

### Claim 10 (depends on 9)

A compound according to claim 9 wherein R30 is —OCH3.

### Claim 11 (depends on 2)

A compound according to claim 2 wherein Z is a 6-membered heterocycle and wherein A is nil, X is C(O), Y is N, and R2 is hydrogen.

### Claim 12 (depends on 11)

A compound according to claim 11 wherein R8, R9, and R10 are each, independently, selected from the group consisting of hydrogen and nil.

### Claim 13 (depends on 12)

A compound according to claim 12 which is: 73
wherein R24 is selected from the group consisting of nil, hydrogen, and alkyl, and R25 and R26 are each, independently, selected from the group consisting of nil, hydrogen, alkyl, alkenyl, heteroalkyl, heteroalkenyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, arylalkenyl, heteroarylalkenyl, halogen, hydroxy, oxo, alkoxy, aryloxy, — SR27, —SO2R27, —SOR27, —COR27, —C(O)OR27, —C(O)NR29R27, —CSR27, —OR27, and —NR27R28, wherein R27, R28, and R29 are each, independently, selected from the group consisting of hydrogen, alkyl, alkenyl, heteroalkyl, heteroalkenyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, arylalkenyl, and heteroarylalkenyl.

### Claim 14 (depends on 13)

A compound according to claim 13 which is selected from the group consisting of: 74

### Claim 15 (depends on 11)

A compound according to claim 11 wherein R7 and R8 are bonded together to form a carbocyclic or heterocyclic aromatic ring.

### Claim 16 (depends on 15)

A compound according to claim 15 which is selected from the group consisting of: 75
wherein R18, R19, and R20 are each, independently, selected from the group consisting of nil, alkyl, alkenyl, heteroalkyl, heteroalkenyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, arylalkenyl, heteroarylalkenyl, halogen, hydroxy, oxo, alkoxy, aryloxy, —SR21, —S(O2)R21, —S(O)R21, —C(O)R21, —C(O)OR21, —C(O)NR21R23, —C(S)R21, —OR21, and —NR21R22, and wherein R18 and R19 may be bonded together to form a 5-, 6-, or 7-membered carbocyclic or heterocyclic ring; wherein R21, R22, and R23 are each, independently, selected from the group consisting of hydrogen, alkyl, alkenyl, heteroalkyl, heteroalkenyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, arylalkenyl, and heteroarylalkenyl.

### Claim 17 (depends on 16)

A compound according to claim 16 wherein R18, R19, and R20 are each, independently, hydrogen.

### Claim 18 (depends on 16)

A compound according to claim 16 which is selected from the group consisting of: 76
wherein R30 is selected from the group consisting of —OR32 and —OCH2C(O)OR32, wherein R32 is selected from the group consisting of hydrogen and alkyl, and wherein R31, is selected from the group consisting of hydrogen, alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, arylalkyl, and heteroarylalkyl.

### Claim 19 (depends on 18)

A compound according to claim 18 wherein R30 is —OCH3.

### Claim 20 (depends on 1)

A composition comprising a compound according to claim 1 and a pharmaceutically-acceptable carrier.

### Claim 21 (depends on 20)

A method of treating hair loss comprising administering to a mammal a composition according to claim 20.

### Claim 22 (depends on 21)

A method according to claim 21 wherein the administration is topical.

### Claim 23 (depends on 21)

A method according to claim 21 wherein the administration is oral.

### Claim 24 (depends on 20)

A method of treating or preventing multi-drug resistance comprising administering to a mammal a composition according to claim 20.

### Claim 25 (depends on 20)

A composition according to claim 20 additionally comprising a matrix metalloproteinase inhibitor.
